scholarly article | Q13442814 |
review article | Q7318358 |
P2093 | author name string | Joan K Morris | |
Nicholas J Wald | |||
P2860 | cites work | Dietary fat intake and prevention of cardiovascular disease: systematic review | Q28361678 |
Blood pressure, stroke, and coronary heart disease | Q29391703 | ||
Neural-tube defects | Q33772419 | ||
Quantifying the effect of folic acid | Q34469951 | ||
Systematic underestimation of association between serum cholesterol concentration and ischaemic heart disease in observational studies: data from the BUPA study | Q36743999 | ||
By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? | Q36884264 | ||
Folic acid and the prevention of neural tube defects | Q40908039 | ||
Folate levels and neural tube defects. Implications for prevention | Q71516278 | ||
P433 | issue | 7415 | |
P407 | language of work or name | English | Q1860 |
P1104 | number of pages | 3 | |
P304 | page(s) | 616-618 | |
P577 | publication date | 2003-09-01 | |
P1433 | published in | The BMJ | Q546003 |
P1476 | title | Teleoanalysis: combining data from different types of study | |
P478 | volume | 327 |
Q38569364 | A journey into clinical evidence: from case reports to mixed treatment comparisons |
Q34019310 | A manifesto for clinical pharmacology from principles to practice |
Q83502017 | Adverse drug reactions |
Q24670053 | Anecdotes that provide definitive evidence |
Q46612312 | De testimonio: on the evidence for decisions about the use of therapeutic interventions |
Q46884329 | Detection of spironolactone-associated hyperkalaemia following the Randomized Aldactone Evaluation Study (RALES). |
Q28750270 | Evaluating the causal relevance of diverse risk markers: horizontal systematic review |
Q57286518 | Evaluation and stages of surgical innovations |
Q80791998 | Gold standards in pharmacovigilance: the use of definitive anecdotal reports of adverse drug reactions as pure gold and high-grade ore |
Q47213346 | How should we evaluate research on counselling and the treatment of depression? A case study on how the National Institute for Health and Care Excellence's draft 2018 guideline for depression considered what counts as best evidence |
Q40028428 | Multiparameter evidence synthesis in epidemiology and medical decision-making |
Q26801502 | State of the Art on the Evidence Base in Cardiac Regenerative Therapy: Overview of 41 Systematic Reviews |
Q33994300 | Systematic review to support the development of nutrient reference intake values: challenges and solutions |
Q28218100 | Systematic reviews of adverse effects: framework for a structured approach |
Q24650519 | The evolution of evidence hierarchies: what can Bradford Hill's 'guidelines for causation' contribute? |
Q38505127 | Toward standardized reporting of drug interactions: the READI checklist for anecdotal reports |
Q30239838 | Validation and calibration of structural models that combine information from multiple sources |
Q21198836 | Why do we need Cases Journal? |
Search more.